Cardiac Metastasis of Malignant Melanoma Detected by 18F-FDG PET/CT-Reference-Cited by-同舟云学术

Cardiac Metastasis of Malignant Melanoma Detected by 18F-FDG PET/CT

Published:2023-06-30 Issue:13 Volume:13 Page:2234
ISSN:2075-4418
Container-title:Diagnostics
language:en
Short-container-title:Diagnostics

Author:

Zhang Hongzhe¹²,Luo Yaping¹²^ORCID

Affiliation:

1. Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing 100730, China

2. Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing 100730, China

Abstract

A 63-year-old man with a history of right plantar malignant melanoma (T3bN0M0, IIb) developed multiple metastases in bilateral lungs 19 months after surgery. Subsequent 18F-FDG PET/CT revealed multiple pulmonary metastases with intense FDG uptake and detected a hypermetabolic lesion in the lateral wall of the left ventricle, which was considered to be a cardiac metastasis of malignant melanoma. This lesion was later confirmed in the dynamic myocardial perfusion MR. This case demonstrates the effectiveness of 18F-FDG PET/CT in detecting occult cardiac metastases of malignant melanoma.

Funder

National High-Level Hospital Clinical Research Funding

Publisher

MDPI AG

Subject

Clinical Biochemistry

Link

https://www.mdpi.com/2075-4418/13/13/2234/pdf

Reference13 articles.

1. Cardiac Metastasis from Solid Cancers: A 35-Year Single-Center Autopsy Study;Guarch;Arch. Pathol. Lab. Med.,2022

2. Cardiac involvement in melanoma: A case report and review of the literature;Tas;J. Cancer Res. Ther.,2010

3. Cardiac metastases;Bussani;J Clin Pathol.,2007

4. Cardiac tumours: Diagnosis and management;Butany;Lancet Oncol.,2005

5. Metastatic malignant melanoma manifesting as an intracardiac mass;Wood;Cardiovasc. Pathol.,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rare Axillary Lymph Node Metastasis on 18F-FDG PET/CT for Staging in a Patient with Common Bile Duct Cancer;Diagnostics;2023-09-21

2. Imatinib;Reactions Weekly;2023-09-02